Jean-Pierre, who suffers from lung cancer and has been receiving treatment for ten years, is in a critical situation. This septuagenarian who lives in Favières, Lorraine, cannot afford his medication, which costs 600 euros. “I fought against an illness, now I have to fight to cure myself,” summarizes the retiree before the BFMTV microphone. Last April, when picking up his monthly dose of medication at the pharmacy, the retiree discovered that IRESSA 250 mg, from the AstraZeneca laboratory, only reimbursed him 60%, that is, the price of the generic. Until then, however, IRESSA had been fully reimbursed by social security, which has left Jean-Pierre in a delicate situation for several months. Because the septuagenarian tried generic medications, made from the same molecule as IRESSA. But none of them suit you, the side effects are too serious. “Impossible to take them,” he says.
Source: BFM TV
